Day: May 15, 2024

Singapore, May 15, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading provider of AI-powered, digital-first education solutions, announced today its financial results for the year ended December 31, 2023. Business Highlights for Fiscal 20232023 audited revenue increased 27% to $23.1 million from $18.2 million in 2022. Pro forma 2023 revenue increased 150% to $70.4 million from $28.1 million in 2022, including revenue from the FatBrain AI transaction. Students and users increased 24% to 5.5 million from 4.4 million in 2022. Gross profit increased to $11.9 million or 52% of revenue compared to $8.6 million, or 47% of revenue in 2022. Net loss after tax reduced 90% to ($5.7) million compared to ($56.0) million in 2022. On a pro forma basis, net loss...

OLD GREENWICH, Conn., May 15, 2024 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP), (“Star Equity” or the “Company”), a diversified holding company, announced today that it will release its financial results for the first quarter ended March 31, 2024, before the market opens on Monday, May 20, 2024. A conference call is scheduled for 10:00 a.m. ET (7:00 a.m. PT) on May 20, 2024, to discuss the results and management’s outlook. The call may be accessed by dialing:Toll Free: 1-833-630-1956 International: 1-412-317-1837A simultaneous webcast of the call may be accessed online from the Events & Presentations link, on the Investor Relations page of the Star Equity website at: https://www.starequity.com/events-and-presentations/presentations. An archived replay of the webcast will be available shortly after...

CHARLOTTE, N.C., May 15, 2024 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“Cheetah Net” or the “Company”) (NASDAQ: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to be sold in the PRC market and a logistics and warehouse service provider, today announced the closing of its follow-on offering of 13,210,000 shares of Class A common stock. Each share of Class A common stock was sold at an offering price of $0.62, for gross proceeds of $8.19 million, before deducting placement agent fees and other offering fees and expenses. All the shares of Class A common stock were offered by the Company. Cheetah Net intends to use the net proceeds received from the offering to fund working capital and to develop its warehousing and logistics services. AC Sunshine Securities LLC acted as the sole placement agent...

Beverly Hills, California., May 15, 2024 (GLOBE NEWSWIRE) — Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing Nordic and U.S. Life Sciences companies with optimal conditions to establish themselves on the U.S. market, announced today that it has entered into an agreement with Orocidin A/S (“Orocidin”) to acquire a 95% stake from eleven of Orocidin’s shareholders for $38,000,000. Nordicus will be issuing 38 million restricted common shares in an all-stock transaction to the selling shareholders. With Nordicus becoming Orocidin’s single largest shareholder, Henrik Rouf, CEO of Nordicus, and Henrik Keller, Director of Nordicus, will both join Orocidin’s Board of Directors. Henrik Rouf stated, “We are thrilled to become the largest shareholder of Orocidin,...

DUBLIN, Ireland, May 15, 2024 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), an emerging leader in the green hydrogen sector, today announced that on May 8, 2024, the Company received a deficiency notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, since the Company’s Form 20-F for the fiscal year ended December 31, 2023 reported shareholders’ equity of $3,022,125, the Company no longer complied with Nasdaq listing rules (the “Rules”) requiring companies listed on the Nasdaq Global Market to maintain a minimum of $10,000,000 in shareholders’ equity. Under the Rules, the Company has 45 calendar days from the date of the Notice to submit a plan (the “Plan”) to regain compliance. If the Plan is accepted, Nasdaq...

PRESS RELEASE        Paris, 15 May 2024 – 17 h 45 YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Stable activity in 1st quarter 2024€36.4 million in revenues for the first three months of the year, stable compared with 1st quarter 2023 (-2%) Leasing revenue on owned equipment up +13.1%Total restated revenue for the 1st quarter 2024 amounts to €36.4 million (€36.6 million at constant currency and scope1), stable compared to €37.1 million of restated revenue at the same period in 2023.Restated Revenue from activities (*) Q1 2024   Q1 2023   Variation  (in € thousand)Leasing revenue on owned equipment 19,381 17,139 2,242Ancillary services 3,021 5,031 -2,010Total leasing activity 22,402 22,170 232Sales of owned equipment 12,213 13,053 -840Total sales of equipment 12,213 13,053 -840Total...

PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15, 2024, at 6.00 pm CESTAccelerated clinical efforts to roll-out PHAXIAM’s strategy in order to create a global phage-therapy leader in high-value indications Cash and cash equivalents of €5.8 million, as of March 31, 2024Lyon (France) and Cambridge (MA, US), May 15, 2024, at 5.45 pm CEST – PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today provides a business and financial update for the first quarter of 2024. Thibaut du Fayet, Chief Executive Officer of PHAXIAM Therapeutics, stated: “Almost a year after the creation of PHAXIAM, the company is well on track to become a leading player in phage therapies targeting...

Strasbourg, France, May 15, 2024, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 15, 2024) at 10:00 a.m. at the Company’s headquarters (400 boulevard Gonthier d’Andernach – Parc d’Innovation – 67400 Illkirch-Graffenstaden, France). The meeting was chaired by Alessandro Riva, Chairman and CEO, to approve the Company’s financial statements for the year ended December 31, 2023, and to vote on the other resolutions submitted for approval. The replay of the Combined General Meeting is available via Transgene’s website and here.   The Combined General Meeting adopted all resolutions recommended by the Board of Directors. The Combined General Meeting notably has appointed one new director, Michel Baguenault de Puchesse, as non-independent director. Michel Baguenault de...